To evaluate the potential effect of
estrogens in premenopausal female
thyroid cancer, the concentrations of 14
estrogens were quantitatively determined in the urine of pre- and post-operative patients with thyroid papillary
cancer (18 patients case, 26 approximately 54 years) and normal female subjects (20 cases, 31 approximately 52 years). The highly sensitive gas chromatography-mass spectrometry-selected ion-monitoring method was used for
estrogens analysis. And an
estrogen-oxidative metabolism and 16alpha-hydroxyestrone to
2-hydroxyestrone (16alpha-
OH E1/2-
OH E1) which is the two primary and competing site of
estrogen-oxidation, were determined.
Catechol estrogens, including 2-OH E1, were also increased without significant changes of the other
estrogen metabolites in pre-operative patients with thyroid papillary
cancer compared with normal subjects. The lowest mean value of 16alpha-OH E1/2-
OH E1 was remarked in pre-operative patients, and it was significantly different from the ratio of post-operative cases. As a result, it is suggested that the increase of 2-hydroxylation in
estrogen metabolism may have a significant association with female
thyroid cancer.